Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 2, 2015, Pages 351-359.e1

  Mashiko, Shunya ^a   Bouguermouh, Salim ^a   Rubio, Manuel ^a   Baba, Nobuyasu ^b   Bissonnette, Robert ^c   Sarfati, Marika ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b KOCHI MEDICAL SCHOOL   (Japan)

^c INNOVADERM RESEARCH   (Canada)

Author keywords

atopic dermatitis; IL 17; IL 22; Mast cells; psoriasis; T cells

Indexed keywords

CD14 ANTIGEN; CD3 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 22; MESSENGER RNA; IL17A PROTEIN, HUMAN; IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; STEM CELL FACTOR RECEPTOR;

ARTICLE; ATOPIC DERMATITIS; CELL COUNT; CELL ISOLATION; CELL POPULATION; CLINICAL ARTICLE; EX VIVO STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LIMIT OF QUANTITATION; MAST CELL; MEMORY T LYMPHOCYTE; ONCOGENE C KIT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS; PUNCH BIOPSY; SKIN BIOPSY; SKIN CELL; T LYMPHOCYTE; GENE EXPRESSION; GENETICS; IMMUNOLOGY; PATHOLOGY; PRIMARY CELL CULTURE; SKIN;

ANTIGENS, CD3; CELL COUNT; DERMATITIS, ATOPIC; GENE EXPRESSION; HUMANS; INTERLEUKIN-17; INTERLEUKINS; MAST CELLS; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS C-KIT; PSORIASIS; RECEPTORS, IGE; RECEPTORS, INTERLEUKIN-17; RNA, MESSENGER; SKIN; T-LYMPHOCYTES;

EID: 84937020799     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.01.033     Document Type: Article

References (51)

1. G.K. Perera, P. Di Meglio, and F.O. Nestle Psoriasis Annu Rev Pathol 7 2012 385 422
2. M.A. Lowes, M. Suarez-Farinas, and J.G. Krueger Immunology of psoriasis Annu Rev Immunol 32 2014 227 255
3. E. Volpe, N. Servant, R. Zollinger, S.I. Bogiatzi, P. Hupe, E. Barillot, and et al. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses Nat Immunol 9 2008 650 657
4. J.T. Elder, A.T. Bruce, J.E. Gudjonsson, A. Johnston, P.E. Stuart, T. Tejasvi, and et al. Molecular dissection of psoriasis: integrating genetics and biology J Invest Dermatol 130 2010 1213 1226
5. M. Cargill, S.J. Schrodi, M. Chang, V.E. Garcia, R. Brandon, K.P. Callis, and et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes Am J Hum Genet 80 2007 273 290
6. F. Capon, P. Di Meglio, J. Szaub, N.J. Prescott, C. Dunster, L. Baumber, and et al. Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis Hum Genet 122 2007 201 206
7. H. Sofen, S. Smith, R.T. Matheson, C.L. Leonardi, C. Calderon, C. Brodmerkel, and et al. Guselkumab (an IL-23-specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis J Allergy Clin Immunol 133 2014 1032 1040
8. A.B. Gottlieb, F. Chamian, S. Masud, I. Cardinale, M.V. Abello, M.A. Lowes, and et al. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques J Immunol 175 2005 2721 2729
9. K.A. Papp, C. Leonardi, A. Menter, J.P. Ortonne, J.G. Krueger, G. Kricorian, and et al. Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis N Engl J Med 366 2012 1181 1189
10. R.G. Langley, B.E. Elewski, M. Lebwohl, K. Reich, C.E. Griffiths, K. Papp, and et al. Secukinumab in plaque psoriasis - results of two phase 3 trials N Engl J Med 371 2014 326 338
11. L. Dumoutier, C. Leemans, D. Lejeune, S.V. Kotenko, and J.C. Renauld Cutting edge: STAT activation by IL-19, IL-20 and mda-7 through IL-20 receptor complexes of two types J Immunol 167 2001 3545 3549
12. K. Wolk, S. Kunz, E. Witte, M. Friedrich, K. Asadullah, and R. Sabat IL-22 increases the innate immunity of tissues Immunity 21 2004 241 254
13. S. Rutz, C. Eidenschenk, and W. Ouyang IL-22, not simply a Th17 cytokine Immunol Rev 252 2013 116 132
14. M.B. Teunissen, J.M. Munneke, J.H. Bernink, P.I. Spuls, P.C. Res, A. Te Velde, and et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR ILC3 in lesional skin and blood of psoriasis patients J Invest Dermatol 134 2014 2351 2360
15. Y. Cai, X. Shen, C. Ding, C. Qi, K. Li, X. Li, and et al. Pivotal role of dermal IL-17-producing gammadelta T cells in skin inflammation Immunity 35 2011 596 610
16. R.R. Keijsers, A.G. Hendriks, P.E. van Erp, B. van Cranenbroek, P.C. van de Kerkhof, H.J. Koenen, and et al. In vivo induction of cutaneous inflammation results in the accumulation of extracellular trap-forming neutrophils expressing RORgammat and IL-17 J Invest Dermatol 134 2014 1276 1284
17. F. Villanova, B. Flutter, I. Tosi, K. Grys, H. Sreeneebus, G.K. Perera, and et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis J Invest Dermatol 134 2014 984 991
18. U. Laggner, P. Di Meglio, G.K. Perera, C. Hundhausen, K.E. Lacy, N. Ali, and et al. Identification of a novel proinflammatory human skin-homing Vγ9Vδ2 T cell subset with a potential role in psoriasis J Immunol 187 2011 2783 2793
19. A.M. Lin, C.J. Rubin, R. Khandpur, J.Y. Wang, M. Riblett, S. Yalavarthi, and et al. Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis J Immunol 187 2011 490 500
20. H.R. Rodewald, and T.B. Feyerabend Widespread immunological functions of mast cells: fact or fiction? Immunity 37 2012 13 24
21. J. Kalesnikoff, and S.J. Galli New developments in mast cell biology Nat Immunol 9 2008 1215 1223
22. M.F. Gurish, and K.F. Austen Developmental origin and functional specialization of mast cell subsets Immunity 37 2012 25 33
23. L. Chen, M.E. Schrementi, M.J. Ranzer, T.A. Wilgus, and L.A. DiPietro Blockade of mast cell activation reduces cutaneous scar formation PLoS One 9 2014 e85226
24. L. Ackermann, I.T. Harvima, J. Pelkonen, V. Ritamaki-Salo, A. Naukkarinen, R.J. Harvima, and et al. Mast cells in psoriatic skin are strongly positive for interferon-gamma Br J Dermatol 140 1999 624 633
25. W.Y. Jiang, A.D. Chattedee, S.P. Raychaudhuri, S.K. Raychaudhuri, and E.M. Farber Mast cell density and IL-8 expression in nonlesional and lesional psoriatic skin Int J Dermatol 40 2001 699 703
26. M.A. Lowes, T. Kikuchi, J. Fuentes-Duculan, I. Cardinale, L.C. Zaba, A.S. Haider, and et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells J Invest Dermatol 128 2008 1207 1211
27. F.I. Lee, S.V. Bellary, and C. Francis Increased occurrence of psoriasis in patients with Crohn's disease and their relatives Am J Gastroenterol 85 1990 962 963
28. L. Chapuy, M. Bsat, H. Mehta, M. Rubio, K. Wakahara, V.Q. Van, and et al. Basophils increase in Crohn disease and ulcerative colitis and favor mesenteric lymph node memory TH17/TH1 response J Allergy Clin Immunol 134 2014 978 981.e1
29. J.H. Bernink, C.P. Peters, M. Munneke, A.A. te Velde, S.L. Meijer, K. Weijer, and et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues Nat Immunol 14 2013 221 229
30. S. Cheuk, M. Wiken, L. Blomqvist, S. Nylen, T. Talme, M. Stahle, and et al. Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis J Immunol 192 2014 3111 3120
31. K. Boniface, E. Guignouard, N. Pedretti, M. Garcia, A. Delwail, F.X. Bernard, and et al. A role for T cell-derived interleukin 22 in psoriatic skin inflammation Clin Exp Immunol 150 2007 407 415
32. J. Meephansan, K. Ruchusatsawat, W. Sindhupak, P.S. Thorner, and J. Wongpiyabovorn Effect of methotrexate on serum levels of IL-22 in patients with psoriasis Eur J Dermatol 21 2011 501 504
33. L. Dumoutier, J. Louahed, and J.C. Renauld Cloning and characterization of IL-10-related T cell-derived inducible factor (IL-TIF), a novel cytokine structurally related to IL-10 and inducible by IL-9 J Immunol 164 2000 1814 1819
34. B. Toruniowa, and S. Jablonska Mast cells in the initial stages of psoriasis Arch Dermatol Res 280 1988 189 193
35. S. Toyry, J. Fraki, and R. Tammi Mast cell density in psoriatic skin. The effect of PUVA and corticosteroid therapy Arch Dermatol Res 280 1988 282 285
36. K. Wolk, E. Witte, E. Wallace, W.D. Docke, S. Kunz, K. Asadullah, and et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis Eur J Immunol 36 2006 1309 1323
37. Y. Zheng, D.M. Danilenko, P. Valdez, I. Kasman, J. Eastham-Anderson, J. Wu, and et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis Nature 445 2007 648 651
38. N. Gaudenzio, C. Laurent, S. Valitutti, and E. Espinosa Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype J Allergy Clin Immunol 131 2013 1400 1407.e11
39. A.J. Hueber, D.L. Asquith, A.M. Miller, J. Reilly, S. Kerr, J. Leipe, and et al. Mast cells express IL-17A in rheumatoid arthritis synovium J Immunol 184 2010 3336 3340
40. T. Noordenbos, N. Yeremenko, I. Gofita, M. van de Sande, P.P. Tak, J.D. Canete, and et al. Interleukin-17-positive mast cells contribute to synovial inflammation in spondylarthritis Arthritis Rheum 64 2012 99 109
41. J. Suurmond, A.L. Dorjee, M.R. Boon, E.F. Knol, T.W. Huizinga, R.E. Toes, and et al. Mast cells are the main interleukin 17-positive cells in anticitrullinated protein antibody-positive and -negative rheumatoid arthritis and osteoarthritis synovium Arthritis Res Ther 13 2011 R150
42. B. Wang, L. Li, Y. Liao, J. Li, X. Yu, Y. Zhang, and et al. Mast cells expressing interleukin 17 in the muscularis propria predict a favorable prognosis in esophageal squamous cell carcinoma Cancer Immunol Immunother 62 2013 1575 1585
43. M.A. Grimbaldeston, S. Nakae, J. Kalesnikoff, M. Tsai, and S.J. Galli Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B Nat Immunol 8 2007 1095 1104
44. I. Shefler, M. Pasmanik-Chor, D. Kidron, Y.A. Mekori, and A.Y. Hershko T cell-derived microvesicles induce mast cell production of IL-24: relevance to inflammatory skin diseases J Allergy Clin Immunol 133 2014 217 224 e1-3
45. S.M. Sa, P.A. Valdez, J. Wu, K. Jung, F. Zhong, L. Hall, and et al. The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis J Immunol 178 2007 2229 2240
46. A.B. Van Belle, M. de Heusch, M.M. Lemaire, E. Hendrickx, G. Warnier, K. Dunussi-Joannopoulos, and et al. IL-22 is required for imiquimod-induced psoriasiform skin inflammation in mice J Immunol 188 2012 462 469
47. S. Kumari, M.C. Bonnet, M.H. Ulvmar, K. Wolk, N. Karagianni, E. Witte, and et al. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice Immunity 39 2013 899 911
48. M. Takaishi, K. Nakajima, W. Ouyang, and S. Sano Psoriasis-like skin lesions are dependent on IL-23 but develop in the absence of IL-22 in a model mouse J Dermatol Sci 73 2014 261 264
49. Pfizer. A single dose study of the safety, tolerability, pharmacokinetics, pharmacodynamics and clinical activity of ILV-095 administered subcutaneously to subjects with psoriasis. Available at: http://clinicaltrial.gov/ct2/show/study/NCT01010542?term=ilv-095&rank=1:NLM Identifier: NCT00004451. Accessed August 11, 2014.
50. K. Wolk, H. Haugen, W. Xu, E. Witte, K. Waggie, M. Anderson, and et al. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-γ are not J Mol Med 87 2009 523 536
51. Y. Lai, D. Li, C. Li, B. Muehleisen, K.A. Radek, H.J. Park, and et al. The antimicrobial protein REG3A regulates keratinocyte proliferation and differentiation after skin injury Immunity 37 2012 74 84